Not all that bad. Sales of systems were not what we expected / hoped. But AP&C doubled its order intake compared to the same period 2015.
What does this mean? Are we selling more powder for SLM systems? Or is it all for EBM systems? Suppose most of it is sold for EBM systems, then a lot of users are making a shift from prototyping / testing to serial production.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.